Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Strimvelis Market Report 2025

Strimvelis Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Clinical Indication (Primary Indication, Patient Population, Clinical Study Data, Mechanism Of Action), By Distribution Channel (Hospitals, Pharmacies), By End User (Pediatric, Adult)

Strimvelis Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Strimvelis Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Strimvelis Market Definition

Strimvelis refers to a gene therapy designed to treat adenosine deaminase deficiency-severe combined immunodeficiency (ADA-SCID). It utilizes a patient’s own stem cells, which are harvested, genetically modified to correct the faulty ADA gene, and then reintroduced into the patient to restore immune function and treat ADA-SCID.

The main types of clinical indication in strimveliare are primary indication, patient population, clinical study data, and mechanism of action. The primary indication for Strimvelis is the treatment of Severe Combined Immunodeficiency (SCID) due to Adenosine Deaminase (ADA) deficiency. It is distributed through hospitals and pharmacies and catering to various end users, such as pediatric and adult.

Strimvelis Market Segmentation

The strimvelis market covered in this report is segmented –

1) By Clinical Indication: Primary Indication; Patient Population; Clinical Study Data; Mechanism Of Action

2) By Distribution Channel: Hospitals; Pharmacies

3) By End User: Pediatric; Adult

Strimvelis Market Size and growth rate 2025 to 2029: Graph

Strimvelis Market Size 2025 And Growth Rate

The strimvelis market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing genetic counseling, increasing use of precision medicine, increasing use of advanced diagnostics, increasing availability of clinical trials, and increasing collaboration with healthcare providers.

Strimvelis Market Growth Forecast

The strimvelis market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the development of companion diagnostics, broader insurance coverage, expansion into emerging markets, emerging gene therapy competitors, and patient advocacy and support organizations. Major trends in the forecast period include vector development and optimization, nanotechnology for targeted therapy, microrna-based gene therapies, the integration of digital twins, and advancements in lentiviral vectors.

Book your 30 minutes free consultation with our research experts

Contact Us

Strimvelis Market Driver: Increase In Rare Genetic Disorders Is Driving Growth In Market

The increase in rare genetic disorders is expected to propel the growth of the strimvelis market going forward. Rare genetic disorders refer to conditions caused by mutations or changes in an individual's DNA and occur infrequently in the general population. The increasing prevalence of genetic disorders can be due to advancements in genetic testing leading to better detection, environmental influences, and, in some cases, lifestyle factors that contribute to mutations in DNA. Strimvelis is a gene therapy that helps rare genetic disorders, particularly adenosine deaminase severe combined immunodeficiency (ADA-SCID), by using the patient's own modified stem cells to introduce a functional copy of the ADA gene, thereby restoring immune function and offering a potential long-term cure for individuals with this rare, life-threatening condition. For instance, in September 2023, according to a report published by the Cystic Fibrosis Trust, a UK-based national charity, in the UK, the number of people registered with cystic fibrosis surpassed 11,000 in 2022, reflecting a significant increase compared to the previous year. Therefore, the increase in rare genetic disorders is driving growth in the strimvelis market.

Strimvelis Market Driver: Rising Healthcare Expenditure Is Expected To Propel The Growth Of The Market

The rising healthcare expenditure is expected to propel the growth of the strimvelis market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare services and products within a specific time frame, usually measured annually. Rising healthcare expenditure is due to an aging population, increasing prevalence of chronic diseases, advancements in medical technology, higher costs of pharmaceuticals, and the expansion of healthcare access and services. Healthcare expenditure plays a crucial role in supporting therapies such as strimvelis by providing the necessary funding for research, development, accessibility, and administration of innovative treatments, ensuring that patients with rare diseases can receive life-saving interventions. For instance, in December 2023, according to a report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, in 2022, U.S. healthcare spending increased by 4.1%, totaling $4.5 trillion, showing a faster rise compared to the 3.2% growth seen in 2021. Therefore, the rising healthcare expenditure is driving growth in the strimvelis market.

Strimvelis Market Driver: Growing Adoption Of Personalized Medicine Is Expected To Propel The Growth Of The Market

The growing adoption of personalized medicine is expected to propel the growth of the strimvelis market going forward. Personalized medicine refers to a medical approach that tailors treatment and healthcare strategies to the individual characteristics of each patient. The growing adoption of personalized medicine is due to the increasing availability of precision diagnostic tools, a shift toward value-based healthcare, and the rising demand for more effective and tailored treatment options that improve patient outcomes. Strimvelis helps personalized medicine by providing a targeted gene therapy that is tailored to individual patients with adenosine deaminase severe combined immunodeficiency (ADA-SCID), using their own stem cells to deliver a functional copy of the ADA gene, offering a customized and potentially curative treatment approach based on the patient's unique genetic profile. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the approval of 12 new personalized medicines accounted for around 34% of all newly approved therapies, marking a significant increase compared to previous years. Therefore, the growing adoption of personalized medicine is driving growth in the strimvelis market.

Global Strimvelis Market Major Players

Major companies operating in the strimvelis market are Orchard Therapeutics plc

Regional Analysis For The Global Strimvelis Market

North America was the largest region in the strimvelis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the strimvelis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the strimvelis market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Strimvelis Market?

The strimvelis market consists of sales of products including libmeldy, zolgensma, luxturna, roctavian, and skysona. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Strimvelis Industry?

The strimvelis market research report is one of a series of new reports from The Business Research Company that provides strimveli market statistics, including strimveli industry global market size, regional shares, competitors with a strimveli market share, detailed strimveli market segments, market trends and opportunities, and any further data you may need to thrive in the strimveli industry. This strimveli market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Strimvelis Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The strimvelis market covered in this report is segmented –
1) By Clinical Indication: Primary Indication; Patient Population; Clinical Study Data; Mechanism Of Action
2) By Distribution Channel: Hospitals; Pharmacies
3) By End User: Pediatric; Adult
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Orchard Therapeutics plc
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Strimvelis Market Characteristics

    3. Strimvelis Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Strimvelis Market Trends And Strategies

    5. Strimvelis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Strimvelis Growth Analysis And Strategic Analysis Framework

    6.1. Global Strimvelis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Strimvelis Market Growth Rate Analysis

    6.4. Global Strimvelis Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Strimvelis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Strimvelis Total Addressable Market (TAM)

    7. Global Strimvelis Pricing Analysis & Forecasts

    8. Strimvelis Market Segmentation

    8.1. Global Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Primary Indication

    Patient Population

    Clinical Study Data

    Mechanism Of Action

    8.2. Global Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Pharmacies

    8.3. Global Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Pediatric

    Adult

    9. Global Strimvelis Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Strimvelis Market Regional And Country Analysis

    10.1. Global Strimvelis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Strimvelis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Strimvelis Market

    11.1. Asia-Pacific Strimvelis Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Strimvelis Market

    12.1. China Strimvelis Market Overview

    12.2. China Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Strimvelis Market

    13.1. India Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Strimvelis Market

    14.1. Japan Strimvelis Market Overview

    14.2. Japan Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Strimvelis Market

    15.1. Australia Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Strimvelis Market

    16.1. South Korea Strimvelis Market Overview

    16.2. South Korea Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Strimvelis Market

    17.1. Western Europe Strimvelis Market Overview

    17.2. Western Europe Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Strimvelis Market

    18.1. UK Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Strimvelis Market

    19.1. Germany Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Strimvelis Market

    20.1. France Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Strimvelis Market

    21.1. Eastern Europe Strimvelis Market Overview

    21.2. Eastern Europe Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Strimvelis Market

    22.1. North America Strimvelis Market Overview

    22.2. North America Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Strimvelis Market

    23.1. USA Strimvelis Market Overview

    23.2. USA Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Strimvelis Market

    24.1. Canada Strimvelis Market Overview

    24.2. Canada Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Strimvelis Market

    25.1. South America Strimvelis Market Overview

    25.2. South America Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Strimvelis Market

    26.1. Middle East Strimvelis Market Overview

    26.2. Middle East Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Strimvelis Market

    27.1. Africa Strimvelis Market Overview

    27.2. Africa Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Strimvelis Market Competitive Landscape And Company Profiles

    28.1. Strimvelis Market Competitive Landscape

    28.2. Strimvelis Market Company Profiles

    28.2.1. Orchard Therapeutics plc Overview, Products and Services, Strategy and Financial Analysis

    28.2.2. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.3. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.4. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.5. 0 Overview, Products and Services, Strategy and Financial Analysis

    29. Global Strimvelis Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Strimvelis Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Strimvelis Market

    32. Recent Developments In The Strimvelis Market

    33. Strimvelis Market High Potential Countries, Segments and Strategies

    33.1 Strimvelis Market In 2029 - Countries Offering Most New Opportunities

    33.2 Strimvelis Market In 2029 - Segments Offering Most New Opportunities

    33.3 Strimvelis Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Strimvelis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Strimvelis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Orchard Therapeutics plc Financial Performance
  • Table 60: 0 Financial Performance
  • Table 61: 0 Financial Performance
  • Table 62: 0 Financial Performance
  • Table 63: 0 Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Strimvelis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Strimvelis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Strimvelis Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Strimvelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Strimvelis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Orchard Therapeutics plc Financial Performance
  • Figure 60: 0 Financial Performance
  • Figure 61: 0 Financial Performance
  • Figure 62: 0 Financial Performance
  • Figure 63: 0 Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

Global Protein Purification And Isolation Market 2022 – Market Opportunities And Strategies

Read More

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

Read More

Gene Therapy Market 2023 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Cell And Gene Therapy Market 2021 - By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Nucleic Acid Based Gene Therapy Global Market Report 2025 – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Gene Therapy Global Market Report 2025 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell and Gene Therapy Global Market Report 2025 – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell & Gene Therapy Manufacturing Services Global Market Report 2025 – By Type (Gene Therapy, Cell Therapy), By Indication (Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases), By Application (Commercial Manufacturing, Clinical Manufacturing), By End-user (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2025 – By Type Of Software Solution (Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System), By Mode Of Deployment (Cloud-Based Solution, On-Premises Solution), By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components), By Application Area (Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up), By End User (Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nucleic Acid Based Gene Therapy Market 2022 - By Nucleic Acid Technology (Anti-Sense and Anti-Gene Oligonucleotides, siRNA and RNA Interference, Gene Transfer Therapy, Ribozymes, Aptamers), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Strimvelis market?

Strimvelis refers to a gene therapy designed to treat adenosine deaminase deficiency-severe combined immunodeficiency (ADA-SCID). It utilizes a patient’s own stem cells, which are harvested, genetically modified to correct the faulty ADA gene, and then reintroduced into the patient to restore immune function and treat ADA-SCID. For further insights on the Strimvelis market, request a sample here

How will the Strimvelis market drivers and restraints affect the market dynamics? What forces will shape the Strimvelis industry going forward?

The Strimvelis market major growth driver - Increase In Rare Genetic Disorders Is Driving Growth In Market. For further insights on the Strimvelis market, request a sample here

What is the forecast market size or the forecast market value of the Strimvelis market?

The Strimvelis market size has grown strongly in recent years. The strimvelis market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing genetic counseling, increasing use of precision medicine, increasing use of advanced diagnostics, increasing availability of clinical trials, and increasing collaboration with healthcare providers. The strimvelis market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the development of companion diagnostics, broader insurance coverage, expansion into emerging markets, emerging gene therapy competitors, and patient advocacy and support organizations. Major trends in the forecast period include vector development and optimization, nanotechnology for targeted therapy, microrna-based gene therapies, the integration of digital twins, and advancements in lentiviral vectors. For further insights on the Strimvelis market, request a sample here

How is the Strimvelis market segmented?

The strimvelis market covered in this report is segmented –
1) By Clinical Indication: Primary Indication; Patient Population; Clinical Study Data; Mechanism Of Action
2) By Distribution Channel: Hospitals; Pharmacies
3) By End User: Pediatric; Adult For further insights on the Strimvelis market, request a sample here

Which region has the largest share of the Strimvelis market? What are the other regions covered in the report?

North America was the largest region in the strimvelis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the strimvelis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Strimvelis market, request a sample here.

Who are the major players in the Strimvelis market?

Major companies operating in the strimvelis market are Orchard Therapeutics plc . For further insights on the Strimvelis market, request a sample here.

What are the key trends in the Strimvelis market?

Major trends in the Strimvelis market include . For further insights on the Strimvelis market, request a sample here.

What are the major opportunities in the Strimvelis market? What are the strategies for the Strimvelis market?

For detailed insights on the major opportunities and strategies in the Strimvelis market, request a sample here.

How does the Strimvelis market relate to the overall economy and other similar markets?

For detailed insights on Strimvelis's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Strimvelis industry?

For detailed insights on the mergers and acquisitions in the Strimvelis industry, request a sample here.

What are the key dynamics influencing the Strimvelis market growth? SWOT analysis of the Strimvelis market.

For detailed insights on the key dynamics influencing the Strimvelis market growth and SWOT analysis of the Strimvelis industry, request a sample here.